HYOU1 and neoplasm: In addition to altered expression of GRP170 in the different stage of breast cancer, the upregulation of GRP170 correlated with tumor lymph node invasion and decreased expression of estrogen receptor (93), implicating its potential involvement in cancer metastasis.